Opinion: Use systems redesign and the law to prevent medical errors and accidents
This summer, surgeons at University Hospitals in Cleveland transplanted a donor kidney into the wrong…
Category: Biotech
Alzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm
For all the explosive controversy over the approval of the first treatment for Alzheimer’s disease…
STAT+: FDA to importer: keep your active pharma ingredients away from weed killer and antifreeze
What do weed killer, engine antifreeze coolant, dry wall repair products, and active pharmaceutical ingredients…
A heart attack app, misinfo crackdowns, and MRI-safe headphones
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: STAT+ Conversation: Dealing with the Delta variant
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Sanofi to pay $3.2 billion to buy Translate Bio; COVAX struggles with Covid-19 vaccine distribution
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
Opinion: Regulating digital health apps needs user-centered reform
When people seek health information, they expect what they get to be reliable and accurate….
.jpg)
Opinion: Punishing drug use heightens the stigma of addiction
Our understanding of substance use disorders as chronic but treatable health conditions has come a…
STAT+: Amylyx is breaking all of biotech’s unwritten rules — and still raising impressive sums
If you want to raise big money in biotech, there are a few unwritten rules….
People chasing Covid-19 vaccine boosters create headaches for the health care system
WASHINGTON — The entire U.S. health care system has been single-mindedly focused on getting Covid-19…
With Apple’s backing, can an app help heart attack patients navigate recovery?
In July 2016, two cardiologists and a handful of computer scientists and developers rolled up…
STAT+: Sanofi pays $3 billion to purchase Translate, raising stakes around mRNA technology
Major drug makers are getting into mRNA, the technology behind the Moderna and Pfizer-BioNTech Covid…
STAT+: ‘Deeply disappointed’: FTC pulls pay-to-delay case after losing authority to force drug makers to relinquish profits
The Federal Trade Commission has reluctantly withdrawn a remaining claim in a lawsuit over a…
STAT+: Pharmalittle: Pfizer and Moderna raise Covid-19 vaccine prices for Europe; FDA to speed full approval of Pfizer shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
No new monkeypox cases reported after health officials monitor hundreds
No new cases of monkeypox have been identified among the people monitored for possible exposure…
Opinion: STAT+: Stifling biopharma mergers would kill the innovation economy that generates new therapies
The headlines speak of a biotech boom with news of company launches, oversubscribed private financings,…
Opinion: ‘Here be dragons’: Long-term survivors like me can help map the boundaries of cancer
“I hope to see you again in six months!” I call back to my radiation…
‘A mini-engineering feat’: High-tech headphones drown out the scary noises inside an MRI
For many people, entering the confinement of an MRI machine can be harrowing: Scans can…
For many, the belated realization that Covid will be ‘a long war’ sparks anger and denial
In May, when the CDC said fully vaccinated people could ditch masks and social distancing,…
Retired neurologist with Alzheimer’s knows firsthand the risks of Aduhelm
Daniel Gibbs had received only four monthly doses of Biogen’s experimental Alzheimer’s drug in a…
Opinion: A close brush with gun violence made me think about how to confront an epidemic during a pandemic
How do we cope with an epidemic in the middle of a pandemic? It’s a…
What Delta has changed in the Covid pandemic — and what it hasn’t
In some respects, the Delta variant has changed everything in the Covid-19 pandemic. In others,…
FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval
WASHINGTON — Under heavy pressure, the Food and Drug Administration center that reviews vaccines is…
STAT+: Pharmalittle: Remdesivir props up Gilead’s declining fortunes; U.K. fines drug maker for price hikes
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: Alzheimer’s scientists critique Cassava Sciences’ study results — overblown, inappropriate, uninterpretable
Independent researchers are expressing doubts about the purported benefits of an experimental treatment for Alzheimer’s…
Opinion: Health care innovation can’t quit now that we are ahead
As health care companies raised a record-breaking $31.6 billion during the first quarter of 2021,…
Opinion: Smoothing the path to fighting food insecurity
Many Americans take good nutrition for granted. They shouldn’t. Hunger is a growing problem in the…
Overdose data, often scattered and siloed, pose challenges for researchers racing to predict risk
As fatal overdoses once again rise — accounting for 92,183 deaths in 2020, a 30%…
States could get billions from opioid lawsuits. They have to decide how to spend it
The endgame of the sprawling mass of opioid lawsuits is starting to come into focus:…
Biden wants $100 rewards for those who get vaccinated against Covid-19 — but there’s little he can do to make it happen
WASHINGTON – President Biden wants states to give $100 to people who get vaccinated against…
Opinion: Clinical research doesn’t reflect the Alzheimer’s population. That needs to change
New data from the National Institute on Aging (NIA), part of the National Institutes of…
Listen: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen
How long do vaccines last? Is the microbiome overhyped? And who should play Jennifer Doudna…
STAT+: Congress presses the FDA to move faster on ALS drugs
WASHINGTON — Lawmakers pressed a top Food and Drug Administration official Thursday for answers on…
STAT+: FDA threatens to fine another drug maker for failing to report clinical trial results
For only the second time, the Food and Drug Administration is threatening to fine a…
STAT+: New research exploring centenarians’ gut microbiomes reveals a potential clue to their longevity
New research into the microbiomes of centenarians reveals a potential clue to their longevity, adding…
Opinion: The FDA just broke the logjam on interchangeable biologics. Here’s what that decision means
The Food and Drug Administration’s decision on Wednesday to approve a long-acting insulin called Semglee…
With Amwell’s deal, the acquisition race heats up in telehealth
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Virtual event: The next battles in the war against HIV
Despite many strides in treatment and prevention, the HIV epidemic continues and disproportionately impacts women…
STAT+: Pharmalittle: Emergent to resume Covid-19 vaccine production; FDA OKs first interchangeable biosimilar insulin
Hello, everyone, and how are you today? We are just fine, thank you, despite gray…
Opinion: A double vaccine crisis is endangering millions of children
World health experts met recently to discuss an emerging global health crisis linked to the…
Opinion: With Aduhelm, history can repeat itself by following cancer’s success
The Food and Drug Administration’s approval of Biogen’s Alzheimer’s drug Aduhelm has stirred intense controversy,…
STAT+: Here’s why simply approving Aduhelm can’t guarantee a golden age of Alzheimer’s R&D
Since the controversial approval of the Alzheimer’s drug Aduhelm, both the Food and Drug Administration…
STAT+: FDA approves the first interchangeable biosimilar insulin. Will it really lower the cost?
In a long-awaited move, the Food and Drug Administration has approved the first so-called interchangeable…
STAT+: Hospitals and pharma are both on the hook to help fund infrastructure deal
WASHINGTON — Both hospitals and drug makers are on the hook to help pay for…
STAT+: Lawmakers ask Defense Department about using a controversial maneuver to lower drug prices
Three years ago, Congress directed the Department of Defense to take steps to lower the…
.jpg)
Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months, data show
The efficacy of the Covid-19 vaccine developed by Pfizer and BioNTech fell from 96% to…
STAT+: Deep Genomics raises $180 million to automate drug discovery
Brendan Frey, the founder and chief executive of Deep Genomics, thinks the wrong people are…
Opinion: Pharmacoequity: a new goal for ending disparities in U.S. health care
The Covid-19 pandemic has brought to the public’s attention alarming racial disparities in health. According…
STAT+: Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales
Top of the morning to you, and a fine one, it is. Delicious cool breezes…
Opinion: Listen: A journalist on what the Vietnam War taught us about addiction
In this week’s episode of the “First Opinion Podcast,” science journalist and author Lauren Aguirre…